Clinical trial
Translational Research - Observational Study for Identification of New Possible Prognostic Factors and Future Therapeutic Targets in Children With Acute Lymphoblastic Leukemia (ALL)
NCT01185886 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Translational Research - Observational Study for Identification of New Possible Prognostic Factors and Future Therapeutic Targets in Children With Acute Lymphoblastic Leukemia (ALL)
- Lead sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2011
- Completion date
- June 30, 2021
- Enrollment
- 1,200 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.